The Promise of Personalized Medicine | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Personalized Medicine in NSCLC

Gene Sequencing – to the Bedside »

The Promise of Personalized Medicine

March 3, 2013 by larryhbern

The Promise of Personalized Medicine

Reporter: Larry H Bernstein, MD, FCAP

Realizing the Promise of Personalized Medicine

Harvard Business Review

MG Aspinal, RG Hamermesh

Obsolete business models, regulations, reimbursement systems, and physicians stand in the way

http://missionfacilitators.com/Articles/Organizational-development/Articles/realizing-the-promise-of-personalized-medicine.pdf/

NewYear for Angels

NewYear for Angels (Photo credit: Wikipedia)

BusinessModel

BusinessModel (Photo credit: Wikipedia)

Harvard Business Review and Fifth Global Peter Drucker Forum Form Partnership (prweb.com)
Is Your Company Ready for the Circular Economy? – Eric Hellweg – Harvard Business Review (entrepreneurshipmatters.com)
Kaggle Visualization Contest yields insights on influence at Harvard Business Review, by @stephanieoverby (nextlevelofnews.com)
Attitudes of Patients about Personalized Medicine (pharmaceuticalintelligence.com)
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

Posted in FDA Regulatory Affairs, Genome Biology, Genomic Testing: Methodology for Diagnosis, Health Economics and Outcomes Research, Health Law & Patient Safety, Molecular Genetics & Pharmaceutical, Nanotechnology for Drug Delivery, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Population Health Management, Genetics & Pharmaceutical, Regulated Clinical Trials: Design, Methods, Components and IRB related issues, Technology Transfer: Biotech and Pharmaceutical | Tagged Business, Business model, Education, Harvard Business Review, Harvard Business School, Harvard University, Larry H. Bernstein, Massachusetts, United States | 1 Comment

One Response

on March 27, 2013 at 7:00 PM | Reply Genomic Liberty of Ownership, Genome Medicine and Patenting the Human Genome | Pharmaceutical Intelligence

I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette

Loading...

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,459 other subscribers
Recent Posts
- Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
- The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
- Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
- Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
- Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
- Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
- Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
- Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: